Ensho Therapeutics
PrivateLast Round
Early Funding
Oct 2, 2026
Total Funding Raised
$28.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ensho Therapeutics is a biopharmaceutical company that develops oral therapies for patients with inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ensho Therapeutics Comparables
Compare Ensho Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorriso Therapeutics | 82% | |
| Eli Lilly and Company | 81% | |
| Protagonist Therapeutics Inc | 79% |
Ensho Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 2, 2026 | ||||
| Series A | Jan 20, 2026 | ||||
| Debt | Sep 12, 2025 | ||||
| Series A | Oct 24, 2024 | ||||
| Seed | Jul 19, 2024 |
Key People
Founding team and executive leadership
Ensho Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series A |
| RM Global Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2026
Raised $7.3M in early funding.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
Ensho Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ensho Therapeutics's valuation, stock price, and market status.
Is Ensho Therapeutics a public or private company?
Ensho Therapeutics is a private company.
What is the current stock price of Ensho Therapeutics?
Ensho Therapeutics is a private company, so its shares have no public market price. Caplight tracks Ensho Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ensho Therapeutics worth (valuation)?
Valuation information for Ensho Therapeutics is not publicly available.
Can I buy Ensho Therapeutics stock?
Ensho Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ensho Therapeutics's last funding round?
Ensho Therapeutics's most recent funding round was Early Funding on October 2, 2026.
Who are the main investors in Ensho Therapeutics?
Key investors in Ensho Therapeutics include Avego Management, RM Global Partners.
Will Ensho Therapeutics IPO soon?
No public IPO plans have been announced for Ensho Therapeutics.
How can I track Ensho Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Ensho Therapeutics's shares on secondary markets.